| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | SKINCURE ONCOLOGY |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $160,000 | |
| 2026 | SKINCURE ONCOLOGY |
3rd Quarter (July 1 - Sep 30) AMENDED |
— | — | |
| 2026 | SKINCURE ONCOLOGY |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination |
— | $130,000 | |
| 2026 | SKINCURE ONCOLOGY |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $100,000 | |
| 2025 | SKINCURE ONCOLOGY |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | $120,000 | |
| 2025 | SKINCURE ONCOLOGY |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $120,000 | |
| 2025 | SKINCURE ONCOLOGY |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $130,000 | |
| 2025 | SKINCURE ONCOLOGY |
3rd Quarter (July 1 - Sep 30) Registration |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| SKINCURE ONCOLOGY | 8 | — |
| Name | Disclosed Prior Position |
|---|---|
| MARK HABBAS |